Given I dont read daily papers apart from afr, it was either an afr or a sunday telegraph about 2 weeks ago.
The news piece was made as a fairly major announcement of a product whereby self-injectors could look to the future with this product and nasal inhalation. Not a lot of facts in the article, and I dont know much about diabetes.It certainly didnt link the article to EIF, that was my leap of paranoia.
I was concerned because it was my understanding that these guys had initially targeted insulin, thats all.
EIF
eiffel technologies limited
